In the first part of our interview with Michael Shortreed, we discuss his winning the Al Yergey MS Scientist Award and learn about his research on computational methods.

Acrivon Therapeutics, Inc.’s ACRV share price has dipped by 7.04%, which has investors questioning if this is right time to ...

Standard BioTools Inc.’s LAB share price has dipped by 5.28%, which has investors questioning if this is right time to buy.

Akoya Biosciences (AKYA) and Enable Medicine announced a collaboration to deliver the largest commercially available single-cell spatial ...

The Enable Atlas’s spatial proteomics layer was generated using Akoya’s PhenoCycler-Fusion, the industry’s fastest and most scalable spatial biology platform, and included the ultrahigh-plex IO60 ...

Morgans analyst Iain Wilkie maintained a Sell rating on Proteomics International Laboratories Ltd. (PIQ – Research Report) today and set a ...

Groundbreaking longevity research initiative brings together leading scientists and institutions to decode the genetic basis ...

Proteomics profiling of a pre-metastatic colorectal cancer cohort identifies four proteomics-based subtypes and highlights ...

In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story behind ...

The Australian precision diagnostics firm said it will use the money to support the launch of its proteomic tests in Australia and the US.

Proteomics International Laboratories has locked in $4.5m to fast-track the roll-out of its Promarker diabetes, oesophageal and endometriosis tests in Australia and the US.

Prostate cancer is one of the most frequently diagnosed cancers in men. Prostate tumor staging and disease aggressiveness are evaluated based on the Gleason scoring system, which is further used to ...